Inhibitory potency and specificity of subtilase-like pro-protein convertase (SPC) prodomains.
about
Identification and characterization of three members of the human metallocarboxypeptidase gene familyMolecular identification of a malaria merozoite surface sheddaseFurin Processing and Proteolytic Activation of Semliki Forest VirusMicroneme Protein 5 Regulates the Activity of Toxoplasma Subtilisin 1 by Mimicking a Subtilisin ProdomainStepwise proteolytic activation of type I procollagen to collagen within the secretory pathway of tendon fibroblasts in situ.Targeting host cell furin proprotein convertases as a therapeutic strategy against bacterial toxins and viral pathogensFunctional characterization of the propeptide of Plasmodium falciparum subtilisin-like protease-1Optimization of protease-inhibitor interactions by randomizing adventitious contactsInhibition of furin/proprotein convertase-catalyzed surface and intracellular processing by small molecules.Autocatalytic activation of the furin zymogen requires removal of the emerging enzyme's N-terminus from the active site.A femtomol range FRET biosensor reports exceedingly low levels of cell surface furin: implications for the processing of anthrax protective antigenFunctional analysis of the cucumisin propeptide as a potent inhibitor of its mature enzyme.An atypical proprotein convertase in Giardia lamblia differentiation.Proteolytic processing of angiopoietin-like protein 4 by proprotein convertases modulates its inhibitory effects on lipoprotein lipase activity.Furin is the major processing enzyme of the cardiac-specific growth factor bone morphogenetic protein 10.Inhibition of prohormone convertases PC1/3 and PC2 by 2,5-dideoxystreptamine derivatives.Loss of endothelial furin leads to cardiac malformation and early postnatal death.Proprotein convertase subtilisin/kexin type 4 in mammalian fertility: a review.Inflammatory proprotein convertase-matrix metalloproteinase proteolytic pathway in antigen-presenting cells as a step to autoimmune multiple sclerosis.Serine Proteases of Malaria Parasite Plasmodium falciparum: Potential as Antimalarial Drug Targets.On the cutting edge of proprotein convertase pharmacology: from molecular concepts to clinical applications.Therapeutic uses of furin and its inhibitors: a patent review.Single amino acid substitution in the PC1/3 propeptide can induce significant modifications of its inhibitory profile toward its cognate enzyme.Development of protein-based inhibitors of the proprotein of convertase SKI-1/S1P: processing of SREBP-2, ATF6, and a viral glycoprotein.Structure-function analysis of the prosegment of the proprotein convertase PC5A.Propeptides as modulators of functional activity of proteases.Posttranslational processing of FGF23 in osteocytes during the osteoblast to osteocyte transition.PACE4 inhibitors and their peptidomimetic analogs block prostate cancer tumor progression through quiescence induction, increased apoptosis and impaired neovascularisation.A novel subtilase inhibitor in plants shows structural and functional similarities to protease propeptides.PACE4-based molecular targeting of prostate cancer using an engineered ⁶⁴Cu-radiolabeled peptide inhibitor.Processing of human toll-like receptor 7 by furin-like proprotein convertases is required for its accumulation and activity in endosomes.The Multi-Leu peptide inhibitor discriminates between PACE4 and furin and exhibits antiproliferative effects on prostate cancer cells.Selective and potent furin inhibitors protect cells from anthrax without significant toxicityProteolysis of the membrane type-1 matrix metalloproteinase prodomain: implications for a two-step proteolytic processing and activation.Identification of furin pro-region determinants involved in folding and activation.TACE/ADAM-17 maturation and activation of sheddase activity require proprotein convertase activity.Substrate cleavage analysis of furin and related proprotein convertases. A comparative study.Functional Characterization of Propeptides in Plant Subtilases as Intramolecular Chaperones and Inhibitors of the Mature Protease.Synthetic peptides derived from the prosegments of proprotein convertase 1/3 and furin are potent inhibitors of both enzymesProcessing and trafficking of a prohormone convertase 2 active site mutant
P2860
Q24292275-DD3A8AFE-4138-4F56-9C60-1378647D3340Q24811597-417093C3-99FE-4A5B-9BAF-1501723F1FB4Q27473344-B1C2FDD8-05E4-4842-B434-4AEE12D96046Q27671558-87F5842B-5374-40BA-8724-3ACD8E3D2CB6Q28000068-427F73F9-6226-4316-A190-09139BA33653Q28304369-A8B3CE36-7671-4385-807E-44FA0B5D626AQ30043446-8DD957C2-A9B2-42D9-8193-E0965D037B7FQ30954807-3FBD48A9-6220-4906-8616-77673AF92E92Q33424237-D555D08C-D154-40CD-85E8-3A7B979A20A0Q33427861-27CAD116-8AB7-4F83-99C9-C60161CF0D39Q33619160-289E7908-9AC5-4979-9634-9CE9C168C99BQ34144534-BD8A5052-81BB-426B-B2E7-AA6F0941E1C1Q34477392-71E82E30-D75E-4646-8705-81D8D9D741E8Q34963041-C7371F56-8BFA-42CE-BD1E-CBB86B9EF31DQ35067671-DB8B45BE-8246-4A8C-96F6-0CC84819732AQ35776764-F05F3D56-FE94-4475-8570-877B4AF4F2CBQ36172870-07594B42-944A-4D1B-AEAF-7852E23200CAQ37358452-045A0C33-5E64-4B3D-AA73-B1AB42855A83Q37431837-9FFEDCA7-D429-439A-9F23-3EFFACBF4996Q37706424-AD889D2A-55D6-4FDA-BA0B-9CA88CC64EAFQ37981645-714207ED-6FC6-4F44-9719-1CD847C01D5DQ38309128-BEA879A8-A0BC-49C0-AF03-F30BF1E022DBQ38316911-133BBE1E-6E6F-47E3-BC76-9C125BD09DA1Q38344667-6E99C450-C0E0-4496-AAF3-0D732EA468C7Q38361357-B704B1B3-2EC8-4585-8FF8-B15859D4E8FCQ38472448-EB323B50-42FE-4523-898D-8DA20873EA51Q38514648-C4A64F63-62DF-4858-B8A2-C45300791C0FQ38909525-8805B9AD-2656-4814-80D7-E200DD967386Q38949308-59C46451-D208-4712-A547-B453434161A9Q38956599-8344627E-1ABF-4017-9FC8-2EEA7F439AFBQ39076945-184F4CD9-BF2C-46F8-A124-368E3714197FQ39249464-BC38689F-98C0-465A-ADA1-7C8DF8F07998Q39733285-4BE8A3AD-21B1-4B6B-94CB-D90A1DB073F6Q40067505-50C3F260-B5D8-49AF-9CBE-3695A11A4060Q40596332-E52B4932-4EDB-4700-8B2D-E4B0475C00C2Q40616018-078E838D-0BFA-4907-9703-257444A63D6AQ40643084-3AB27D0E-FDF8-41E1-9529-D6BA97AEE98CQ41049557-97B579CC-897F-4565-9F62-251DCCDD77C8Q42097979-2532FD1D-D04B-4D0A-AED8-3E2F6BBDACE6Q42139486-9B33F505-D0CC-49ED-95D2-606622964F71
P2860
Inhibitory potency and specificity of subtilase-like pro-protein convertase (SPC) prodomains.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Inhibitory potency and specifi ...... n convertase (SPC) prodomains.
@ast
Inhibitory potency and specifi ...... n convertase (SPC) prodomains.
@en
type
label
Inhibitory potency and specifi ...... n convertase (SPC) prodomains.
@ast
Inhibitory potency and specifi ...... n convertase (SPC) prodomains.
@en
prefLabel
Inhibitory potency and specifi ...... n convertase (SPC) prodomains.
@ast
Inhibitory potency and specifi ...... n convertase (SPC) prodomains.
@en
P2093
P2860
P356
P1476
Inhibitory potency and specifi ...... n convertase (SPC) prodomains.
@en
P2093
Frédéric Gagnon
Klaus Klarskov
Martin Fugère
Pierre Lavigne
Polizois C Limperis
Richard Leduc
Robert Day
Véronique Beaulieu-Audy
P2860
P304
P356
10.1074/JBC.M107467200
P407
P577
2001-11-26T00:00:00Z